Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HCA Healthcare, Inc.HCA · Entity 2929 | Director · 10% owner | April 28, 2026 | April 30, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HCA Healthcare, Inc.
Report date April 28, 2026 · Filed April 30, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | Direct | 13,740 |
Reported balance
After 2026-04-28 transaction · row 1
1 source rowRow 1 · 2026-04-28 · Grant · Acquired 809 · Balance 13,740 F1: Represents shares of Common Stock, par value $0.01 per share ("Shares"), of HCA Healthcare, Inc. (the "Issuer") underlying 509 restricted share units attributable to an annual director equity award and 300 restricted share units received in lieu of an annual cash retainer for service as a director. The restricted share units shall vest on the sooner of the date of the 2027 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date. Vested Shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of the Issuer. |
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | IndirectBy Frisco Holding II | 36,557,141 |
Reported balance
Holding disclosure · report date 2026-04-28 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 36,557,141 F2: Frisco Holding II ("Frisco") holds 36,557,141 Shares. Frisco is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to exercise voting and investment control over the Shares held by Frisco, but disclaims beneficial ownership of such Shares except to the extent of his pecuniary interest therein, which may be deemed to include indirect interests in Shares through ownership of Frisco partnership units to the extent of: 3,156,495 Shares by the Reporting Person; and 8,713,110 Shares by trusts for the benefit of the Reporting Person's children of which the Reporting Person or his spouse is trustee. |
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | IndirectBy Hercules Holding II | 32,282,889 |
Reported balance
Holding disclosure · report date 2026-04-28 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 32,282,889 F3: Hercules Holding II ("Hercules") holds 32,282,889 Shares. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to exercise voting and investment control over the Shares held by Hercules, but disclaims beneficial ownership of such Shares except to the extent of his pecuniary interest therein, which may be deemed to include indirect interests in Shares through ownership of Hercules partnership units to the extent of: 941,766 Shares by the Reporting Person; 9,021 Shares by the Reporting Person's spouse and children; 12,287,166 Shares by trusts for the benefit of the Reporting Person's children of which the Reporting Person or his spouse is trustee; and 1,147,830 Shares by family partnerships or vehicles of which the Reporting Person is an officer or managing member. |
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | IndirectBy spouse and children | 1,416 |
Reported balance
Holding disclosure · report date 2026-04-28 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 1,416 |
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | IndirectBy trusts | 340,852 |
Reported balance
Holding disclosure · report date 2026-04-28 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 340,852 F4: These Shares are held by trusts for the benefit of the Reporting Person's children of which the Reporting Person or his spouse is trustee. |
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | IndirectBy family partnerships | 60,678 |
Reported balance
Holding disclosure · report date 2026-04-28 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 60,678 F5: These Shares are held by family partnerships or vehicles of which the Reporting Person is an officer or managing member. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of Common Stock, par value $0.01 per share ("Shares"), of HCA Healthcare, Inc. (the "Issuer") underlying 509 restricted share units attributable to an annual director equity award and 300 restricted share units received in lieu of an annual cash retainer for service as a director. The restricted share units shall vest on the sooner of the date of the 2027 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date. Vested Shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of the Issuer.
F2: Frisco Holding II ("Frisco") holds 36,557,141 Shares. Frisco is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to exercise voting and investment control over the Shares held by Frisco, but disclaims beneficial ownership of such Shares except to the extent of his pecuniary interest therein, which may be deemed to include indirect interests in Shares through ownership of Frisco partnership units to the extent of: 3,156,495 Shares by the Reporting Person; and 8,713,110 Shares by trusts for the benefit of the Reporting Person's children of which the Reporting Person or his spouse is trustee.
F3: Hercules Holding II ("Hercules") holds 32,282,889 Shares. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to exercise voting and investment control over the Shares held by Hercules, but disclaims beneficial ownership of such Shares except to the extent of his pecuniary interest therein, which may be deemed to include indirect interests in Shares through ownership of Hercules partnership units to the extent of: 941,766 Shares by the Reporting Person; 9,021 Shares by the Reporting Person's spouse and children; 12,287,166 Shares by trusts for the benefit of the Reporting Person's children of which the Reporting Person or his spouse is trustee; and 1,147,830 Shares by family partnerships or vehicles of which the Reporting Person is an officer or managing member.
F4: These Shares are held by trusts for the benefit of the Reporting Person's children of which the Reporting Person or his spouse is trustee.
F5: These Shares are held by family partnerships or vehicles of which the Reporting Person is an officer or managing member.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 28, 2026 Filed Apr 30, 2026 19:13 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock, par value $0.01 per share | 809 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-26-018355 · form4.xml · nonDerivative · entry 1 Frist William R · CIK 0001433377 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,740 F1 · kind: Represents shares of Common Stock, par value $0.01 per share ("Shares"), of HCA Healthcare, Inc. (the "Issuer") underlying 509 restricted share units attributable to an annual director equity award and 300 restricted share units received in lieu of an annual cash retainer for service as a director. The restricted share units shall vest on the sooner of the date of the 2027 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date. Vested Shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of the Issuer. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 20:05 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | OtherCommon Stock, par value $0.01 per share | 36,557,141 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-26-004685 · form4.xml · nonDerivative · entry 2 Frist William R · CIK 0001433377 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Frisco Holding II Disclosed balance after: 36,557,141 F1 · kind: On February 6, 2026, Frisco Holding II ("Frisco") disposed of 36,629,188 shares of Common Stock, par value $0.01 per share ("Shares"), of HCA Healthcare, Inc. (the "Issuer"), in exchange for 36,557,141 Shares newly issued by the Issuer to Frisco, in each case, in a transaction exempt from the registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 thereunder. These transactions, together with the conversion of Frisco to an entity taxable as a partnership for U.S. federal income tax purposes, constituted a reorganization for purposes of Section 368(a) of the Internal Revenue Code of 1986, as amended. F1 · price: On February 6, 2026, Frisco Holding II ("Frisco") disposed of 36,629,188 shares of Common Stock, par value $0.01 per share ("Shares"), of HCA Healthcare, Inc. (the "Issuer"), in exchange for 36,557,141 Shares newly issued by the Issuer to Frisco, in each case, in a transaction exempt from the registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 thereunder. These transactions, together with the conversion of Frisco to an entity taxable as a partnership for U.S. federal income tax purposes, constituted a reorganization for purposes of Section 368(a) of the Internal Revenue Code of 1986, as amended. F1 · ownership.nature: On February 6, 2026, Frisco Holding II ("Frisco") disposed of 36,629,188 shares of Common Stock, par value $0.01 per share ("Shares"), of HCA Healthcare, Inc. (the "Issuer"), in exchange for 36,557,141 Shares newly issued by the Issuer to Frisco, in each case, in a transaction exempt from the registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 thereunder. These transactions, together with the conversion of Frisco to an entity taxable as a partnership for U.S. federal income tax purposes, constituted a reorganization for purposes of Section 368(a) of the Internal Revenue Code of 1986, as amended. F2 · ownership.nature: Frisco holds 36,557,141 Shares. Frisco is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to exercise voting and investment control over the Shares held by Frisco, but disclaims beneficial ownership of such Shares except to the extent of his pecuniary interest therein, which may be deemed to include indirect interests in Shares through ownership of Frisco partnership units to the extent of: 3,156,495 Shares by the Reporting Person; and 8,713,110 Shares by trusts for the benefit of the Reporting Person's children of which the Reporting Person or his spouse is trustee. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 20:05 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | OtherCommon Stock, par value $0.01 per share | 36,629,188 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-26-004685 · form4.xml · nonDerivative · entry 1 Frist William R · CIK 0001433377 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Frisco Holding II Disclosed balance after: 0 F1 · kind: On February 6, 2026, Frisco Holding II ("Frisco") disposed of 36,629,188 shares of Common Stock, par value $0.01 per share ("Shares"), of HCA Healthcare, Inc. (the "Issuer"), in exchange for 36,557,141 Shares newly issued by the Issuer to Frisco, in each case, in a transaction exempt from the registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 thereunder. These transactions, together with the conversion of Frisco to an entity taxable as a partnership for U.S. federal income tax purposes, constituted a reorganization for purposes of Section 368(a) of the Internal Revenue Code of 1986, as amended. F1 · price: On February 6, 2026, Frisco Holding II ("Frisco") disposed of 36,629,188 shares of Common Stock, par value $0.01 per share ("Shares"), of HCA Healthcare, Inc. (the "Issuer"), in exchange for 36,557,141 Shares newly issued by the Issuer to Frisco, in each case, in a transaction exempt from the registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 thereunder. These transactions, together with the conversion of Frisco to an entity taxable as a partnership for U.S. federal income tax purposes, constituted a reorganization for purposes of Section 368(a) of the Internal Revenue Code of 1986, as amended. F1 · ownership.nature: On February 6, 2026, Frisco Holding II ("Frisco") disposed of 36,629,188 shares of Common Stock, par value $0.01 per share ("Shares"), of HCA Healthcare, Inc. (the "Issuer"), in exchange for 36,557,141 Shares newly issued by the Issuer to Frisco, in each case, in a transaction exempt from the registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 thereunder. These transactions, together with the conversion of Frisco to an entity taxable as a partnership for U.S. federal income tax purposes, constituted a reorganization for purposes of Section 368(a) of the Internal Revenue Code of 1986, as amended. Read SEC document |
| April 30, 2025 Filed May 1, 2025 19:30 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | OtherCommon Stock, par value $0.01 per share | 10,504.5617 | $340.60 | $3,577,853.72 |
DisclosureSEC source: 0001140361-25-016965 · form4.xml · nonDerivative · entry 2 Frist William R · CIK 0001433377 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · Held indirectly by WRF 2015, LLC Disclosed balance after: 1,574,896.8051 F2 · ownership.nature: Hercules Holding II ("Hercules") holds 68,912,077 shares of common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein. F3 · ownership.nature: The Reporting Person is an officer and a managing member of WRF 2015, LLC and may be deemed to own indirectly the 1,562,273.8051 units of Hercules and the 12,623 shares of common stock of HCA Healthcare, Inc. held by such entity, and may therefore be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc. F4 · ownership.nature: On April 30, 2025, the Reporting Person and the William R. Frist 2010 Family Trust transferred units of WRF 2015, LLC to a trust for the benefit of the Reporting Person's children, of which the Reporting Person's spouse is a trustee. The units transferred corresponded to indirect ownership of a total of 10,420.3663 units of Hercules and 84.1954 shares of common stock of HCA Healthcare, Inc. and were made at a net cash price of $340.60 (the average of the high and low prices of the shares of common stock of HCA Healthcare, Inc. on April 30, 2025) per share of common stock of HCA Healthcare, Inc. or unit of Hercules. In each case, these transfers changed neither the number of units of Hercules or shares of common stock of HCA Healthcare, Inc. held by WRF 2015, LLC, nor the total number of shares of common stock of HCA Healthcare, Inc. of which the Reporting Person may be deemed to have beneficial ownership. Read SEC document |
| April 29, 2025 Filed May 1, 2025 19:30 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock, par value $0.01 per share | 1,026 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-25-016965 · form4.xml · nonDerivative · entry 1 Frist William R · CIK 0001433377 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,931 F1 · kind: Represents common stock of HCA Healthcare, Inc. underlying 645 restricted share units attributable to an annual director equity award and 381 restricted share units received in lieu of an annual cash retainer for service as a director. The restricted share units shall vest on the sooner of the date of the 2026 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date. Vested shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of HCA Healthcare, Inc. Read SEC document |
| April 29, 2024 Filed May 1, 2024 18:23 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock, par value $0.01 per share | 963 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-005454 · doc4.xml · nonDerivative · entry 1 Frist William R · CIK 0001433377 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,905 F1 · kind: Represents common stock underlying 610 restricted share units attributable to an annual director equity award and 353 restricted share units received in lieu of an annual cash retainer for service as a director. The restricted share units shall vest on the sooner of the date of the 2025 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date. Vested shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of HCA Healthcare, Inc. Read SEC document |
| April 24, 2023 Filed Apr 26, 2023 17:05 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock, par value $0.01 per share | 1,047 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-025701 · doc4.xml · nonDerivative · entry 1 Frist William R · CIK 0001433377 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,942 F1 · kind: Represents common stock underlying 663 restricted share units attributable to an annual director equity award and 384 restricted share units received in lieu of an annual cash retainer for service as a director. The restricted share units shall vest on the sooner of the date of the 2024 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date. Vested shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of HCA Healthcare, Inc. Read SEC document |
| April 25, 2022 Filed Apr 27, 2022 18:21 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock, par value $0.01 per share | 1,424 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-025863 · doc4.xml · nonDerivative · entry 1 Frist William R · CIK 0001433377 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,895 F1 · kind: Represents common stock underlying 902 restricted share units attributable to an annual director equity award and 522 restricted share units received in lieu of an annual cash retainer for service as a director. The restricted share units shall vest on the sooner of the date of the 2023 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date. Vested shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of HCA Healthcare, Inc. Read SEC document |
| April 28, 2021 Filed Apr 30, 2021 20:33 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock, par value $0.01 per share | 1,435 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-029400 · doc4.xml · nonDerivative · entry 1 Frist William R · CIK 0001433377 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,471 F1 · kind: Represents common stock underlying 881 restricted share units attributable to an annual director equity award and 554 restricted share units received in lieu of an annual cash retainer for service as a director. The restricted share units shall vest on the sooner of the date of the 2022 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date. Vested shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of HCA Healthcare, Inc. Read SEC document |
| August 12, 2020 Filed Feb 16, 2021 17:33 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock, par value $0.01 per share | 9,507.583 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-010862 · doc5.xml · nonDerivative · entry 1 Frist William R · CIK 0001433377 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held indirectly through Hercules Holding II by the William R. Frist August 2020 GRAT Disclosed balance after: 941,764.95 F1 · ownership.nature: The Reporting Person received a gift of 9,507.582951 units of Hercules Holding II ("Hercules") on August 12, 2020, which were subsequently transferred to the William R. Frist August 2020 GRAT, of which he serves as trustee. Following receipt of this gift, the Reporting Person may be deemed to be the beneficial owner of the units of Hercules held by this trust and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc. F2 · ownership.nature: Hercules holds 68,912,077 shares of common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:10 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock, par value $0.01 per share | 1,668 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-027350 · doc4.xml · nonDerivative · entry 1 Frist William R · CIK 0001433377 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,036 F1 · kind: Represents common stock underlying 1,668 restricted share units which shall vest on the sooner of the date of the 2021 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date. Vested shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of HCA Healthcare, Inc. Read SEC document |
| August 20, 2019 Filed Feb 14, 2020 16:50 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock, par value $0.01 per share | 315.235 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-009722 · doc5.xml · nonDerivative · entry 2 Frist William R · CIK 0001433377 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held indirectly through Hercules Holding II Disclosed balance after: 399,256.7214 F1 · ownership.nature: Hercules Holding II ("Hercules") holds 68,912,077 shares of common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein. F2 · ownership.nature: The Reporting Person directly owns 399,256.72141 units of Hercules and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc. by virtue of his ownership in Hercules. The Reporting Person may also be deemed to have indirect beneficial ownership in respect of 4,128 shares of common stock of HCA Healthcare, Inc. and 78,155.825 units of Hercules, through an indirect pecuniary interest in such shares and units held by his children and spouse, and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc. Read SEC document |
| May 21, 2019 Filed Feb 14, 2020 16:50 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock, par value $0.01 per share | 13,593.169 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-009722 · doc5.xml · nonDerivative · entry 1 Frist William R · CIK 0001433377 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held indirectly through Hercules Holding II Disclosed balance after: 398,941.4864 F1 · ownership.nature: Hercules Holding II ("Hercules") holds 68,912,077 shares of common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein. F2 · ownership.nature: The Reporting Person directly owns 399,256.72141 units of Hercules and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc. by virtue of his ownership in Hercules. The Reporting Person may also be deemed to have indirect beneficial ownership in respect of 4,128 shares of common stock of HCA Healthcare, Inc. and 78,155.825 units of Hercules, through an indirect pecuniary interest in such shares and units held by his children and spouse, and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc. Read SEC document |
| May 01, 2019 Filed May 3, 2019 16:47 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock, par value $0.01 per share | 1,410 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-027409 · doc4.xml · nonDerivative · entry 1 Frist William R · CIK 0001433377 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,368 F1 · kind: Represents common stock underlying 1,410 restricted share units which shall vest on the sooner of the date of the 2020 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date. Vested shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of HCA Healthcare, Inc. Read SEC document |
| May 02, 2018 Filed May 4, 2018 17:20 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock, par value $0.01 per share | 1,790 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-028170 · doc4.xml · nonDerivative · entry 2 Frist William R · CIK 0001433377 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,958 F3 · shares: Represents common stock underlying 1,790 restricted share units which shall vest on the sooner of the date of the 2019 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date. Vested shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of HCA Healthcare, Inc. Read SEC document |
| February 20, 2018 Filed May 4, 2018 17:20 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock, par value $0.01 per share | 22,168 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-028170 · doc4.xml · nonDerivative · entry 1 Frist William R · CIK 0001433377 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held indirectly through Hercules Holding II by The William R. Frist February 2018 GRAT Disclosed balance after: 416,420.6596 F1 · ownership.nature: Hercules Holding II ("Hercules") holds 68,912,077 shares of the common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein. F2 · ownership.nature: The Reporting Person received a gift of 22,168 units of Hercules on February 20, 2018 which were subsequently transferred to The William R. Frist February 2018 GRAT, of which he serves as trustee. Following receipt of this gift, the Reporting Person may be deemed the beneficial owner of the units of Hercules held by this trust and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc. Read SEC document |
| May 22, 2017 Filed Feb 14, 2018 17:39 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock, par value $0.01 per share | 9,366.67 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-010037 · doc5.xml · nonDerivative · entry 1 Frist William R · CIK 0001433377 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held indirectly through Hercules Holding II by William Frist May 2017 GRAT Disclosed balance after: 9,366.67 F1 · ownership.nature: Hercules Holding II ("Hercules") holds 68,912,077 shares of the common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein. F2 · ownership.nature: The Reporting Person received a gift of 9,366.67 units of Hercules on May 22, 2017, which were subsequently transferred to The William Frist May 2017 GRAT, of which he serves as trustee. Following receipt of this gift, the Reporting Person may be deemed the beneficial owner of the units of Hercules held by this trust and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc. Read SEC document |
| May 03, 2017 Filed May 5, 2017 20:43 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock, par value $0.01 per share | 2,112 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-030360 · doc4.xml · nonDerivative · entry 2 Frist William R · CIK 0001433377 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,168 F3 · shares: Represents common stock underlying 2,112 restricted share units which shall vest on the sooner of the date of the 2018 annual shareholders' meeting of HCA Holdings, Inc. or the first anniversary of the grant date. Vested shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of HCA Holdings, Inc. F4 · ownership.direct: The Reporting Person directly owns 56 shares of common stock of HCA Holdings, Inc. The Reporting Person directly owns 1,065.745 units of Hercules and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Holdings, Inc. by virtue of his ownership in Hercules. The Reporting Person may also be deemed to have indirect beneficial ownership in respect of 4,128 shares of common stock of HCA Holdings, Inc. and 78,155.825 units of Hercules, through an indirect pecuniary interest in such shares and units held by his children and his wife, and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Holdings, Inc. Read SEC document |
| February 22, 2017 Filed May 5, 2017 20:43 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock, par value $0.01 per share | 2,348,330.3574 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-030360 · doc4.xml · nonDerivative · entry 1 Frist William R · CIK 0001433377 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held indirectly through Hercules Holding II by Trusts for Children Disclosed balance after: 3,911,150.4071 F1 · ownership.nature: Hercules Holding II ("Hercules") holds 68,912,077 shares of the common stock of HCA Holdings, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist, Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Holdings, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein. F2 · ownership.nature: The Reporting Person's wife is the trustee of six trusts for the benefit of the Reporting Person's children, and the Reporting Person may, accordingly, be deemed to be the beneficial owner of the units of Hercules held by such trusts and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Holdings, Inc. Read SEC document |
| February 17, 2016 Filed Feb 14, 2017 22:55 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock, par value $0.01 per share | 24,731 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-010708 · doc5.xml · nonDerivative · entry 1 Frist William R · CIK 0001433377 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held indirectly through Hercules Holding II by The William Frist February 2016 GRAT Disclosed balance after: 24,731 F1 · ownership.nature: Hercules Holding II ("Hercules") holds 68,912,077 shares of the common stock of HCA Holdings, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist, Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Holdings, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein. On September 23, 2016, Hercules Holding II, LLC, a Delaware limited liability company, was converted into Hercules Holding II, a Delaware general partnership. F2 · ownership.nature: The Reporting Person received a gift of 24,731 units of Hercules on February 17, 2016, which were subsequently transferred to The William Frist February 2016 GRAT, of which he serves as trustee. Following receipt of this gift, the Reporting Person may be deemed the beneficial owner of the units of Hercules held by this trust and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Holdings, Inc. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.